Prostate cancer: open trials in China

253 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07885423
68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer
Trial Treatment · The First Affiliated Hospital of Xiamen University
The First Affiliated hospital of Xiamen University, Xiamen
Registry updated 2026-11-06
NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Beijing Friendship Hospital Affiliate of Capital University ( Site 0396), Beijing · Peking University First Hospital-Urology ( Site 0390), Beijing · Beijing Cancer hospital-Urinary Surgery ( Site 0395), Beijing · Hunan Cancer Hospital ( Site 0405), Changsha · The Third People's Hospital of Chengdu (CDTPH) ( Site 0428), Chengdu · West China Hospital, Sichuan University-Urology Surgery ( Site 0417), Chengdu · Chongqing University Cancer Hospital ( Site 0416), Chongqing · Chongqing Three Gorges Central Hospital's ( Site 0426), Chongqing · Southwest Hospital of Third Military Medical University ( Site 0420), Chongqing · The First Affiliated Hospital of Chongqing Medical University ( Site 0427), Chongqing · The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 0414), Fuzhou · The First Affiliated Hospital of Guangzhou Medical University ( Site 0412), Guangzhou · Sun Yat-sen University Cancer Center-Internal medicine ( Site 0413), Guangzhou · Zhejiang Provincial People's Hospital-Urology ( Site 0378), Hangzhou · Zhejiang Cancer Hospital ( Site 0435), Hangzhou · Second Affiliated hospital of Anhui Medical University-Urology ( Site 0408), Hefei · First Huai'an Hospital Affiliated to Nanjing Medical University ( Site 0436), Huaian · The First Hospital of Jiaxing-urology ( Site 0380), Jiaxing · Yunnan Province Cancer Hospital ( Site 0418), Kunming · The Second Affiliated Hospital Of Kunming Medical University ( Site 0429), Kunming · Jiangxi Cancer Hospital ( Site 0386), Nanchang · Nanchong Central Hospital-urology ( Site 0422), Nanchong · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( Site 0377), Nanjing · The First Affiliated Hospital of Ningbo University ( Site 0383), Ningbo · Zhongshan Hospital Fudan University ( Site 0430), Shanghai · Fudan University Shanghai Cancer Center-Urology department ( Site 0376), Shanghai · Huadong Hospital Affiliated to Fudan University-Urology ( Site 0388), Shanghai · Suining Central Hospital ( Site 0437), Suining · The Second Hospital of Tianjin Medical University ( Site 0391), Tianjin · Tianjin Medical University Cancer Institute & Hospital ( Site 0392), Tianjin · Xinjiang Medical University Cancer Hospital - Urumqi-Urology ( Site 0419), Ürümqi · The First Affiliated Hospital of Wenzhou Medical University-Urology Surgery ( Site 0379), Wenzhou · Hubei Cancer Hospital-Urinary surgery ( Site 0406), Wuhan · Tongji Hospital Tongji Medical,Science & Technology ( Site 0407), Wuhan · Affiliated hospital of Jiangnan university ( Site 0434), Wuxi · The First Affiliated hospital of Xiamen University-Urology ( Site 0415), Xiamen · The First Affiliated Hospital of Xi'an Jiaotong University-Oncology ( Site 0393), Xi'an · The Second Affiliated Hospital of Xi'an Jiaotong University ( Site 0394), Xi'an · Yantai Yuhuangding Hospital ( Site 0397), Yantai
Registry updated 2026-11-05
NCT07450599
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
Trial Treatment · Phase 2 · Bayer
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing · Peking University First Hospital, Beijing · Sichuan Cancer Hospital, Chengdu · Dongyang People's Hospital, Dongyang · The First Affiliated Hospital of Fujian Medical University, Fuzhou · Nanfang Hospital, Guangzhou · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · The 2nd Affiliated Hospital of Harbin Medical University, Harbin · The Second Affiliated Hospital Of Anhui Medical University, Hefei · Qilu Hospital of Shandong University, Jinan · Jinhua Municipal Central Hospital (Affiliated Jinhua Hospital, Zhejiang University School of Medicine), Jinhua · The Second Affiliated Hospital of Kunming Medical University, Kunming · The Second Hospital & Clinical Medical School Lanzhou University, Lanzhou · The First Affiliated Hospital of NanChang University, Nanchang · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing · Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine, Shanghai · Shanghai General Hospital, Shanghai · The First Hospital of China Medical University, Shenyang · The 2nd Hospital of Hebei Medical University, Shijiazhuang · The Second Hospital of Tianjin Medical University, Tianjin · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Renmin Hospital of Wuhan University, Wuhan · The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Registry updated 2026-11-05
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Beijing Cancer Hospital, Beijing · Sun Yat-sen University Cancer Center, Guangzhou · Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
Registry updated 2026-11-04
NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Trial Treatment · Phase 1 · Eli Lilly and Company
Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Beijing · Tianjin Cancer Hospital Airport Hospital, Tianjin
Registry updated 2026-11-04
NCT06095089
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Chongqing University Cancer Hospital, Chongqing · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · The First Affiliated Hospital of Xian Jiaotong University, Xi'an
Registry updated 2026-11-03
NCT06482645
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
Trial Treatment · Peking University First Hospital
Peking University First Hospital, Beijing
Registry updated 2026-11-03
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Peking University First Hospital, Beijing · The First Bethune Hospital of Jilin University, Changchun · West China Hospital of Sichuan University, Chengdu · The Third People's Hospital of Chengdu, Chengdu · Chongqing University Cancer Hospital, Chongqing · Sun Yat-sen University Cancer Center, Guangzhou · Nanjing Drum Tower hospital, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · Nantong Tumor Hospital, Nantong · The First Affiliated Hospital of Ningbo University, Ningbo · Fudan University Shanghai Cancer Center, Shanghai · The Second Hospital of Tianjin Medical University, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Zhongnan Hospital Wu Han University, Wuhan · The First Affiliated Hospital of Xian Jiaotong University, Xi'an
Registry updated 2026-11-03
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Beijing Luhe Hospital, Capital Medical University, Beijing · Beijing Cancer Hospital, Beijing · Peking University First Hospital, Beijing · West China Hospital，Sichuan University, Chengdu · The Third People's Hospital of Chengdu, Chengdu · Chongqing University Cancer Hospital, Chongqing · Sun Yat-sen University Cancer Center, Guangzhou · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Nanjing Drum Tower hospital, Nanjing · Huashan Hospital, Fudan University, Shanghai · Shanghai General Hospital, Shanghai · Xinhua hospital,Shanghai Jiaotong University, Shanghai · The Second Hospital of Tianjin Medical University, Tianjin · The Central Hospital of Wuhan, Wuhan · The First Affiliated Hospital of Xian Jiaotong University, Xi'an
Registry updated 2026-11-03
NCT07832292
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Sun Yat-sen University Cancer Center, Guangzhou · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Registry updated 2026-11-03
NCT06740071
The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy
Trial Treatment · The University of Hong Kong
Ruijin hospital, Shanghai
Registry updated 2026-11-02
NCT04429451
PSMA-specific CAR-T Cell Therapy
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-10-30
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Cancer Hospital Chinese Academy of Medical Science, Beijing · Peking University Third Hospital, Beijing · Hunan Cancer Hospital, Changsha · West China Hospital，Sichuan University, Chengdu · Fujian Cancer Hospital, Fuzhou · Guangzhou First People's Hospital, Guangzhou · The Second Affiliated Hospital of Guilin Medical University, Guilin · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Inner Mongolia People's Hospital, Hohhot · Huai'an First People's Hospital, Huai'an · The First Hospital Of Jiaxing, Jiaxing · Shandong Provincial Hospital, Jinan · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing · Nantong Tumor Hospital, Nantong · The First Affiliated Hospital of Ningbo University, Ningbo · The Affiliated Hospital of Qingdao University, Qingdao · Tongji Hospital of Tongji University, Shanghai · The Second Affiliated Hospital of Shantou University School of Medicine, Shantou · First Affiliated Hospital of China Medical University, Shenyang · The Second Affiliated Hospital of Soochow University, Suzhou · The Second Hospital of Tianjin Medical University, Tianjin · Weifang People's Hospital, Weifang · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Wannan Medical College Yijishan Hospital, Wuhu · Shaanxi Provincial People' Hospital, Xi'an · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang · Yantai Yuhuangding Hospital, Yantai · Henan Cancer Hospital, Zhengzhou
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Shanghai General Hospital ( Site 1449), Beijing · Peking University First Hospital ( Site 1434), Beijing · Jilin Province People's Hospital ( Site 1461), Changchun · Hunan Cancer Hospital ( Site 1411), Changsha · West China Hospital of Sichuan University ( Site 1451), Chengdu · West China Hospital, Sichuan University ( Site 1468), Chengdu · Chongqing University Three Gorges Hospital ( Site 1405), Chongqing · The First Affiliated Hospital of Chonqing Medical University ( Site 1406), Chongqing · The First Affiliated Hospital Of Fujian Medical University ( Site 1452), Fuzhou · Sun Yat-sen Memorial Hospital, Sun Yat-sen University ( Site 1402), Guangzhou · Guangzhou First People's Hospital ( Site 1410), Guangzhou · Sun Yat-sen University Cancer Center ( Site 1409), Guangzhou · Sun Yat-Sen University Cancer Center ( Site 1467), Guangzhou · Zhejiang Cancer Hospital ( Site 1447), Hangzhou · The First Hospital of Jiaxing ( Site 1416), Jiaxing · Shandong Cancer Hospital ( Site 1421), Jinan · Zhongda Hospital Southeast University ( Site 1427), Nanjing · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 1425), Nanjing · Jiangsu Province Hospital ( Site 1426), Nanjing · Guangxi Medical University Cancer Hospital ( Site 1414), Nanning · The First Affiliated Hospital of Ningbo University ( Site 1419), Ningbo · Zhongshan Hospital Fudan University ( Site 1430), Shanghai · Shanghai Tongji Hospital ( Site 1412), Shanghai · Fudan University Shanghai Cancer Center ( Site 1400), Shanghai · Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1457), Shanghai · Shanghai Tenth People's Hospital ( Site 1441), Shanghai · First Affiliated Hospital Of Shanxi Medical University ( Site 1460), Taiyuan · The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 1469), Ürümqi · The First Affiliated Hospital of Wenzhou Medical University ( Site 1437), Wenzhou · Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1424), Wuhan · The first affiliated Hospital of Xi an Jiaotong University ( Site 1408), Xi'an · The Affiliated Hospital of Xuzhou Medical University ( Site 1438), Xuzhou · Henan Cancer Hospital ( Site 1472), Zhengzhou · The Fifth Affiliated Hospital of Sun Yat-Sen University ( Site 1459), Zhuhai
Registry updated 2026-10-30
NCT07907653
Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer
Trial Treatment · Phase 2 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat Sen Memorial Hospital of Sun Yat sen University, Guangzhou
Registry updated 2026-10-30
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Trial Treatment · Phase 1/2 · Pfizer
Cancer Hospital Chinese Academy of Medical Science, Beijing · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Hubei Cancer Hospital, Wuhan · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · Henan Cancer Hospital, Zhengzhou
Registry updated 2026-10-28
NCT07310433
Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
Trial Treatment · Phase 2 · Yung NA
Huashan Hospital, Shanghai · Ruijin hospital, Shanghai
Registry updated 2026-10-28
NCT07897071
AXT-1003 Combination With Enzalutamide in Participants With mCRPC
Trial Treatment · Phase 1 · Axter Therapeutics (Beijing) Co., Ltd
Hunan Cancer Hospital, Changsha · Sun Yet-Sen University Cancer Center, Guangzhou · The First Affiliated Hospital of Ningbo University, Ningbo · Fudan University Shanghai Cancer Center, Shanghai
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
West China Hospital，Sichuan University, Chengdu · Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2026-10-26
NCT07244341
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 1 · Daiichi Sankyo
Sun Yatsen University Cancer Center, Guangzhou · Shanghai General Hospital, Shanghai · Fudan University Shanghai Cancer Center, Shanghai · Fudan University Shanghai Cancer Center - Xuhui District, Shanghai · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Registry updated 2026-10-26
NCT07339267
A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
Trial Treatment · Phase 1 · Astellas Pharma Global Development, Inc.
Beijing Hospital, Beijing
Registry updated 2026-10-26
NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 1/2 · AstraZeneca
Changsha · Chengdu · Wuhan
Registry updated 2026-10-22
NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Pfizer
Beijing Cancer Hospital, Beijing · Jilin Province Tumor Hospital, Changchun · Sun Yat-sen University Cancer Center, Guangzhou · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
Registry updated 2026-10-21
NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · DualityBio Inc.
Baoding · Beijing · Beijing · Beijing · Changchun · Changchun · Changsha · Changsha · Chengdu · Chengdu · Chengdu · Chengdu · Chongqing · Chongqing · Chongqing · Chongqing · Fuzhou · Ganzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Hangzhou · Hangzhou · Hangzhou · Hangzhou · Hangzhou · Harbin · Hefei · Jinan · Jinan · Linyi · Linyi · Luoyang · Nanchang · Nanchang · Nanjing · Nanjing · Nanjing · Nanning · Shanghai · Shanghai · Shanghai · Shenyang · Shenyang · Taizhou · Tianjin · Tianjin · Tianjin · Wuhan · Wuhan · Xi’an · Xinxiang · Zhengzhou · Zhengzhou
Registry updated 2026-10-21
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Beijing · Guangzhou · Shanghai
Registry updated 2026-10-21

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error